Predicting Who Benefits From Gastric Bypass Surgery for Type 2 Diabetes
Studies adults with type 2 diabetes and obesity after gastric bypass surgery.
Key facts
- Who runs it
- Imperial College London
- Where
- London, United KingdomSee the site
- Trial code
- Registry title
- Who Will Benefit From Bariatric Surgery for Diabetes?
- Status
- Recruiting
- People taking part
- 210 people, planned
- Started
- 1 Oct 2018
- Expected to end
- 5 Oct 2028
- Type of study
- Observational, 2 groups
- Treatments tested
- Roux-en-Y gastric bypass (RYGB)
- Record updated
- 19 April 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18-80 planning Roux-en-Y gastric bypass surgery who have type 2 diabetes or prediabetes and obesity. It also takes healthy volunteers as a comparison group.
- Age
- 18-80 years
- Sex
- Men and women can join.
- Disease stage
- Surgery group: type 2 diabetes or prediabetes, with obesity (BMI ≥30kg/m2). Healthy group: BMI 19 - 25 kg/m2.
- Earlier treatment
- Surgery group: planning to have Roux-en-Y gastric bypass (RYGB) and can have surgery on the NHS under the NICE 2014 criteria. Weight must be stable for at least 3 months.
Main reasons for not taking part
- Type 1 diabetes, secondary diabetes, low fasting C-peptide or no β-cell function
- Current pregnancy
- Current smoker
- Cannot have a DEXA scan, or has cirrhosis, ascites or another condition that changes body fat
- Cannot understand English
The registry criteria, word for word
Show all 29 criteriaShow less
Who can take part
- Males and females planning to undergo RYGB
- 18-80 years
- Type 2 diabetes mellitus or prediabetes
- Stable weight for at least 3 months
- Obese (BMI ≥30kg/m2)
- Eligible for surgery on the National Health Service (NHS) under The National Institute for Health and Care Excellence (NICE) 2014 criteria
- Aged 18-80 years
- Male or female
- Body mass index 19 - 25 kg/m2
- Stable weight for at least three months
Who cannot take part
- Type 1 diabetes
- Secondary diabetes or absence of β-cell function
- Unable to undergo DEXA, cirrhosis, ascites, or other condition that may modify body fat composition e.g. underlying malignancy
- History of any medical, or other condition, or use of any medications, including over-the-counter products, which, in the opinion of the investigators, would either interfere with the study
- Abnormal glucose tolerance and fasting glucose
- Current pregnancy
- Inability to give informed consent
- Low fasting C-peptide
- Current smoker
- Participation in another (interventional) trial within the last 3 months
- Unable to understand English; Healthy volunteers
- Without access at home to a telephone, or other factor likely to interfere with ability to participate reliably in the study
- Pregnancy or breastfeeding
- Unable to maintain adequate contraception for the duration of the study
- Donated blood during the preceding 3 months or intention to do so before the end of the study
- Current smoker
- Participation in another trial within the last 3 months
- Unable to understand English
Other criteria
- Bariatric surgery group
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Where in United Kingdom
- Imperial College Healthcare NHS TrustLondon, United KingdomContact: Julia S Kenkre, MB BChirTaking people
About the trial
What the trial wants to find out
A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery.
The 2 groups in the trial
- Surgical cohort
Patients with type 2 diabetes undergoing Roux-en-Y gastric bypass surgery
Treatment: Roux-en-Y gastric bypass (RYGB)
- Control
Healthy volunteers with normal body mass index
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Who Will Benefit From Bariatric Surgery for Diabetes? Using Fat Distribution Measurement, Gut Hormone Profiles and Genetic Data to Predict Diabetes Remission
- Plain-language title
- Predicting Who Benefits From Gastric Bypass Surgery for Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT03842475, who can take part
- Publications
- Record updated
- 19 April 2023